Who is sponsoring NCT05277831?

NCT05277831 is sponsored by University of Arizona.

What drugs are being tested in NCT05277831?

Interventions in NCT05277831: Guided Imagery Intervention, Standard Behavioral Control.

What condition does NCT05277831 study?

NCT05277831 studies Smoking Cessation, Smoking, Smoking Reduction, Smoking, Cigarette, Smoking (Tobacco) Addiction, Smoking Habit.

Is NCT05277831 still recruiting?

NCT05277831 is currently completed. Last updated 24 November 2025.

Last reviewed 2025-11-24 · How we verify

NCT05277831

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testing the Efficacy of A Scalable, Telephone-Delivered, Guided Imagery Tobacco Cessation Intervention

Completed NA Last updated 24 November 2025

What this trial tests

NA trial testing Guided Imagery Intervention in Smoking Cessation in 1,209 participants. Completed in 26 October 2025.

Timeline

1 August 2022

Primary endpoint
26 October 2025

26 October 2025

Quick facts

Lead sponsor	University of Arizona
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	treatment
Enrollment	1,209
Start date	1 August 2022
Primary completion	26 October 2025
Estimated completion	26 October 2025
Sites	1 location across United States

Drugs / interventions tested

Guided Imagery Intervention
Standard Behavioral Control

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →
Smoking — all drugs for Smoking →
Smoking Reduction — all drugs for Smoking Reduction →
Smoking, Cigarette — all drugs for Smoking, Cigarette →

Sponsor

University of Arizona

Who can join

18 and older, any sex, with Smoking Cessation or Smoking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this R01 application is to conduct a randomized controlled trial to test the efficacy of the Be Smoke Free, telephone-based, guided imagery (GI) intervention (IC) for smoking cessation compared to active behavioral control (CC). The study will recruit 1,200 diverse smokers from three states, Arizona, New York, and West Virginia to increase generalizability. Participants will be randomly assigned to receive either the IC or CC delivered by telephone by University of Arizona study coaches and will be assessed at 3- and 6-months post-enrollment by study staff. The primary outcome is biochemically verified 7-day point prevalence abstinence at 6 months. This innovative and rigorously designed project conducted by an experienced team has the potential to improve public health through the delivery of an innovative integrative GI intervention via telephone.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Testing the Efficacy of a Scalable Telephone-Delivered Guided Imagery Tobacco Cessation Treatment: Protocol for a Randomized Clinical Trial.
Gordon JS, Armin JS, Giacobbi P, Hsu CH, et al · · 2023 · cited 2× · PMID 37351932 · DOI 10.2196/48898
Predictors of Enrollment and Adherence in a Randomized Tobacco Cessation Clinical Trial.
Coffee Z, Hsu CH, Vanderah TW, Gordon JS. · · 2024 · PMID 39678308 · DOI 10.1177/1179173x241308136

Verify or expand the search:

Other trials of Guided Imagery Intervention

Trials testing the same drug.

NCT04315675 — Improve Functional Health Status in Minority Women With HIV · NA · unknown

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other University of Arizona trials

Trials by the same sponsor.

NCT04062890 — Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance · Phase 2 · withdrawn
NCT05569486 — Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain · NA · not yet recruiting
NCT05064111 — Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy · suspended
NCT06567899 — Mechanistic Underpinnings of Preeclampsia · not yet recruiting
NCT07254793 — Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05277831 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Arizona
Last refreshed: 24 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05277831.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing